Development code · Small Molecule
TEV-56286
TEV-56286 is a development code for Emrusolmin, developed by Teva Pharmaceutical Industries Ltd..
- Status
- Phase 2 for Multiple System Atrophy
- Mechanism
- Alpha-synuclein Modulator
- Developer
- Teva Pharmaceutical Industries Ltd.
Programs
- Emrusolmin for Multiple System AtrophyPhase 2Recruiting
Also known as
- Emrusolmin
- anle138b
- 3-(2H-1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazole
- 882697-00-9